Argent Advisors, Inc. Eli Lilly & CO Transaction History

Argent Advisors, Inc.

$267 Million
Q3 2024

A detailed history of Argent Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Argent Advisors, Inc. holds 4,041 shares of LLY stock, worth $3.05 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

4,041

Previous 4,046 0.12%

Holding current value

$3.05 Million

Previous $3.66 Million 2.27%

% of portfolio

1.34%

Previous 1.46%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $3,860 - $4,800	-5 Reduced 0.12%	4,041 $3.58 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $7,248 - $9,090	-10 Reduced 0.25%	4,046 $3.66 Million
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $12,436 - $16,637	-21 Reduced 0.52%	4,056 $3.16 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $5,251 - $6,191	-10 Reduced 0.24%	4,077 $2.38 Million
Q3 2023 Nov 08, 2023	BUY	$434.7 - $599.3 $22,169 - $30,564	51 Added 1.26%	4,087 $2.2 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $26,305 - $35,173	-75 Reduced 1.82%	4,036 $1.89 Million
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $6,212 - $7,296	-20 Reduced 0.48%	4,111 $1.41 Million
Q4 2022 Feb 01, 2023	SELL	$321.55 - $374.67 $128,620 - $149,868	-400 Reduced 8.83%	4,131 $1.51 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $24,376 - $29,998	-110 Reduced 2.37%	4,531 $1.05 Million
Q2 2021 Aug 02, 2021	SELL	$180.55 - $233.54 $35,207 - $45,540	-195 Reduced 4.03%	4,641 $1.07 Million
Q1 2021 Apr 27, 2021	BUY	$164.32 - $212.72 $319,273 - $413,314	1,943 Added 67.16%	4,836 $903,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $191,906 - $253,938	-1,471 Reduced 33.71%	2,893 $488,000
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $8,773 - $10,147	-60 Reduced 1.36%	4,364 $646,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $20,053 - $24,134	-147 Reduced 3.22%	4,424 $726,000
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $3,571 - $4,420	-30 Reduced 0.65%	4,571 $634,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $491,938 - $609,310	4,601 New	4,601 $648,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $717B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Eli Lilly & CO Transaction History